The role of immune system parameters in the relationship between depression and coronary artery disease.

The relationship between depressive symptoms and coronary artery disease (CAD) is mediated in part by immune system parameters. This review describes research on the psychoneuroimmunological pathways accounting for the association between depression and CAD, and addresses conceptual and methodological issues. Relationships between central nervous system correlates of depression and immune system parameters are bidirectional and are mediated via neurohormonal and parasympathetic pathways. Evidence suggests that these associations can be affected by a) the clinical characteristics of depression (e.g., typical depression versus atypical depression and exhaustion), b) the duration and severity of depressive symptoms, and c) the stage of underlying CAD. Depressive symptoms are hypothesized to affect primarily the transition from stable CAD to acute coronary syndromes via plaque activation and prothrombotic processes, and may play an additional role in the response to injury at early stages of coronary atherosclerosis.

[1]  S. Segerstrom,et al.  Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. , 2004, Psychological bulletin.

[2]  R. Dantzer,et al.  Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy , 2004, Brain, Behavior, and Immunity.

[3]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[4]  P. Schnohr,et al.  Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample. A prospective study of 4084 men and 5479 women in the Copenhagen City Heart Study. , 2003, International journal of epidemiology.

[5]  S. Rubin,et al.  Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study , 2003, Circulation.

[6]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[7]  A. Döring,et al.  Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men , 2003, Brain, Behavior, and Immunity.

[8]  L. Wulsin,et al.  Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. , 2003, Psychosomatic medicine.

[9]  Russell P Tracy,et al.  Inflammation, the metabolic syndrome and cardiovascular risk. , 2003, International journal of clinical practice. Supplement.

[10]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[11]  A. Johnson,et al.  Biological mechanisms in the relationship between depression and heart disease , 2002, Neuroscience & Biobehavioral Reviews.

[12]  R. Carney,et al.  Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. , 2002, Journal of psychosomatic research.

[13]  L. Fried,et al.  Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. , 2002, The American journal of cardiology.

[14]  Kop Wj,et al.  Assessment and treatment of depression in coronary artery disease patients. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[15]  E. Zorrilla,et al.  The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review , 2001, Brain, Behavior, and Immunity.

[16]  A K Manatunga,et al.  Paroxetine for the prevention of depression induced by high-dose interferon alfa. , 2001, The New England journal of medicine.

[17]  N. Nicolson,et al.  Salivary cortisol patterns in vital exhaustion. , 2000, Journal of psychosomatic research.

[18]  M. Burnett,et al.  Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  M. Bourassa,et al.  Depression and health-care costs during the first year following myocardial infarction. , 2000, Journal of psychosomatic research.

[20]  W. Kop Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. , 1999, Psychosomatic medicine.

[21]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[22]  L. Keltikangas-Järvinen,et al.  Relationships between the pituitary-adrenal hormones, insulin, and glucose in middle-aged men: moderating influence of psychosocial stress. , 1998, Metabolism: clinical and experimental.

[23]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[24]  K. Goodkin,et al.  Behavioral-neuroendocrine-immunologic interactions in myocardial infarction. , 1997, Medical hypotheses.

[25]  W. Kop,et al.  The relationship between severity of coronary artery disease and vital exhaustion. , 1996, Journal of psychosomatic research.

[26]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[27]  S. Cohen,et al.  Depression and immunity: a meta-analytic review. , 1993, Psychological bulletin.

[28]  C. Weisse,et al.  Depression and immunocompetence: a review of the literature. , 1992, Psychological bulletin.

[29]  F. Goodwin,et al.  Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.

[30]  S. Maier,et al.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.

[31]  R. Dantzer,et al.  Stress and immunity: an integrated view of relationships between the brain and the immune system. , 1989, Life sciences.

[32]  I. Savodnik Psychosomatic medicine. , 1978, The Journal of medicine and philosophy.